“This study shows that sacituzumab govitecan, when combined with pembrolizumab as an initial treatment for patients with metastatic triple-negative breast cancer, delivers superior disease control and ...

"These early, interim results from a promising prospective, randomized study evaluating the role of adjuvant chemotherapy in patients with stage IA-IIA non-small cell lung cancer identified as ...

“Trastuzumab deruxtecan is approved for patients with metastatic HER2-positive gastric cancer or gastroesophageal junction adenocarcinoma who received a prior trastuzumab-based regimen based on ...

“In patients with hormone-sensitive metastatic breast cancers that harbored ESR1 mutations, the VERITAC-2 clinical trial found that vepdegestrant worked better than fulvestrant, making it a potential ...

Today the administration released the details of its proposed FY 2026 budget request, including a nearly 40% reduction in funding for the National Institutes of Health (NIH) and the National Cancer ...

The Food and Drug Administration (FDA) is announcing the establishment of a docket to solicit public comment for information on dihydropyrimidine dehydrogenase (DPD) deficiency and the use of ...

The Association for Clinical Oncology (ASCO) is urging the House and Senate Subcommittees on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies to support cancer ...

Luis E. Raez, Xylina T. Gregg, Gurjyot K. Doshi, Scott Freeswick, Austin Cox, Neal Dave, Kashyap B. Patel, Melissa S. Dillmon, Stuart Genschaw, Elizabeth V ...

"This trial raises an intriguing hypothesis: that the increasingly popular GLP-1 medications used to treat diabetes and obesity might offer some benefit in reducing the risk of developing cancer. I ...

“Accurate HER2 scoring is important to ensure that patients receive the best treatment for their breast cancer. This international study shows that an AI-assisted approach improved HER2 scoring, ...

“The INAVO120 trial has identified a targeted treatment regimen that meaningfully improves survival in patients with untreated PIK3CA-mutated hormone receptor-positive metastatic breast cancer – a big ...